News Express

Science News: Early Promise for ANX005 as a Targeted Therapy in Guillain-Barré Syndrome

July 28, 2025

Early Promise is shown for ANX005 as a Targeted Therapy in Guillain-Barré Syndrome.

William Litchy, MD, Receives AANEM's 2025 Lifetime Achievement Award

July 28, 2025

AANEM Attends AMA House of Delegates Meeting

July 16, 2025

Science News: Platelet-Poor Plasma for Muscle Injuries

July 16, 2025

Science News: Clinical Trial Finds Telitacicept Reduces MG Symptoms Within Weeks

June 26, 2025

Clinical Trial Finds Telitacicept Reduces MG Symptoms Within Weeks

Science News: A Better Way to Move: Evaluating Assistive Devices for Easier Ambulation

June 16, 2025

Injuries to the knee, lower leg, ankle, and foot accounted for nearly 17% of all emergency department visits in 2017. Researchers explored if using a hands-free crutch (HFC) displays potential for easier completion of ADLs and reduction in energy requirements.

Trainee Talk: Reflections From the Young Leadership Council Emerging Leaders Forum

June 02, 2025

Dr. Nwebube shares their experience at the 2025 AANEM Young Leadership Council Emerging Leaders Forum.

Science News: Limited Benefit of TFSNRIs in Spinal Stenosis

May 28, 2025

This study is a retrospective analysis of multiple outcome measures evaluated by patient survey looking at the benefit of TFSNI in patients with spinal stenosis and radicular pain

Countdown to Boards: Study Smarter with AANEM’s Exam Resources

May 20, 2025

As the 2025 ABPN and the ABPMR exams approach, residents and physicians face the challenge of balancing clinical responsibilities with comprehensive exam preparation. AANEM offers tools to help prepare.

Science News: Thymectomy Trends in MG After MGTX Trial

May 16, 2025

Thymectomy for Myasthenia Gravis: Utilization Trends and Disparities After the MGTX Trial.

Legislation Aims To Uphold Standards in EDX Medicine

May 08, 2025

Patient Safety: HIPAA Compliance During EDX Documentation

May 05, 2025

The number of ePHI data breaches continues to rise. The HIPAA outlines the administrative, physical, and technical safeguards to prevent such breaches from occurring and minimize harm if they do occur.

Science News: Eculizumab in Severe Guillain‐Barré Syndrome

May 05, 2025

This review discusses the results of eculizumab in cases of severe Guillain-Barré syndrome.

Science News: Improving Muscle Grade Accuracy With EMG

April 17, 2025

This review discusses a study that supports the reliability of MMT in assessment of key muscles in spinal cord injury patients.

CMS Telehealth Flexibilities Extended Through September 2025

April 17, 2025

Congress recently passed legislation extending key Medicare telehealth flexibilities through Sept. 30, 2025. While the recent extension through September 2025 is a positive step, AANEM remains committed to securing lasting legislative solutions that support flexible, patient-centered care.

AANEM's 12th Annual Day on Capitol Hill

April 17, 2025

On March 10, 2025, AANEM held its 12th Annual Day on Capitol Hill, bringing together state liaisons from around the country to advocate for the future of electrodiagnostic (EDX) medicine and the patients it serves.

Patient Safety: Mononeuropathies in Scapular Winging

April 03, 2025

Scapular winging is a clinical sign describing an abnormal prominence of the medial or inferior border of the scapula during arm & shoulder motion. It can be present with a wide range of neurologic, neuromuscular, or musculoskeletal conditions. However, the most common are long thoracic and spinal accessory nerve palsies. These two mononeuropathies can often be differentiated on clinical exam due to either medial or lateral positioning consistent with scapular winging.

Science News: Initial Clinical Experience and Outcomes of Ravulizumab in AChR+ gMG

April 03, 2025

Analyzing a study that evaluates the initial clinical experience of using ravulizumab, a long-acting C5 monoclonal antibody, in patients with acetylcholine receptor antibody-positive generalized myasthenia gravis (AChR+ gMG).

Science News: Long-Term Efficacy and Safety of Apitegromab in Nonambulatory SMA Patients

March 20, 2025

This study examines the long-term efficacy and safety of apitegromab (SRK-015) in nonambulatory patients with SMA over 36 months, showing sustained motor function improvements and a favorable safety profile.

Trainee Talk: Starting Points for the Rising Neuromuscular Fellow

March 20, 2025

Abigail Bose, MD, shares her tips for residents preparing for fellowships.